丹麦三级风湿病中心诊断的VEXAS患者炎症标志物显著升高、大细胞性贫血且自身免疫生物标志物阴性
在丹麦奥胡斯大学医院风湿科,11例临床疑似VEXAS的男性患者接受UBA1基因Sanger测序,5例携带已知VEXAS相关变异。诊断中位年龄84(75-87)岁,所有患者炎症标志物显著升高(CRP中位297(196-386)mg/L)、大细胞性贫血,且常见自身免疫生物标志物均为阴性。
要点
- 5例确诊VEXAS患者均为男性,诊断中位年龄84(75-87)岁。
- 所有患者CRP中位297(196-386)mg/L,呈显著升高。
- 所有患者均有大细胞性贫血且常见自身免疫生物标志物阴性。
核心结论
- 丹麦VEXAS综合征患者为男性,表现为持续性炎症、全身症状和异质性临床表现。
- 本研究中所有患者的共同特征为炎症标志物显著升高、大细胞性贫血和自身免疫生物标志物阴性。
研究设计与样本
- 在丹麦奥胡斯大学医院风湿科识别并诊断患者,由该院临床免疫科采用Sanger测序检测UBA1变异。
- 从医院电子病历中提取临床和生化数据。
- 11例临床疑似VEXAS的男性患者接受测序,其中5例携带已知VEXAS相关变异。
主要发现
- 11例临床疑似VEXAS的男性患者接受测序,5例携带已知VEXAS相关变异。
- 诊断中位年龄为84(75-87)岁。
- 所有患者炎症标志物显著升高,CRP中位297(196-386)mg/L。
- 所有患者均有大细胞性贫血。
- 无患者呈现常见自身免疫生物标志物。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) is an autoinflammatory condition with overlapping features of rheumatology and haematology caused by somatic mutations in the UBA1 gene. Patients present with highly variable symptoms and their path towards diagnosis are often complicated and characterised by extensive examinations. It is, therefore, pivotal that clinicians become familiar with the clinical presentation of VEXAS to advance identification of patients with the disease. OBJECTIVES: We aimed to (1) characterise patients diagnosed with VEXAS in a tertiary rheumatology referral centre, (2) identify common rheumatological biomarkers that may distinguish VEXAS from other rheumatic diseases and (3) suggest which clinical findings should motivate genetic testing for VEXAS. METHODS: Patients were identified and diagnosed at the department of Rheumatology, Aarhus University Hospital (AUH), Denmark. Blood samples were examined for VEXAS-associated UBA1 variants by Sanger sequencing at the department of Clinical Immunology, AUH. Clinical and biochemical data were retrieved from the hospital electronic patient chart. RESULTS: Eleven male patients with clinical suspicion of VEXAS underwent sequencing. Five of these carried known VEXAS-associated variants. Median age at diagnosis was 84 (75-87) years. All patients had significantly elevated inflammatory markers with a median C-reactive protein (CRP) of 297 (196-386) mg/L and macrocytic anaemia. None of the patients presented common biomarkers for autoimmunity. CONCLUSION: Danish patients with VEXAS syndrome are men with persistent inflammation, constitutional symptoms and heterogeneous clinical presentations. Shared features for all patients in this study were highly elevated inflammatory markers, macrocytic anaemia and negative autoimmune biomarkers.
引用
- Rasch MNB, Szabados F, Jensen JMB, et al. Patients with VEXAS diagnosed in a Danish tertiary rheumatology setting have highly elevated inflammatory markers, macrocytic anaemia and negative autoimmune biomarkers. RMD Open. 2022. PMID: 38967099. doi:10.1136/rmdopen-2022-002492
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。